Previvo Genetics (Previvo) is a medical device start-up in the process of bringing a revolutionary pre-implantation genetic diagnosis solution to the planned pregnancy market. Previvo’s founder and inventor, Dr. John Buster, was no stranger to working with ID, engaging them to accelerate the growth of his fertility practice based out of Tufts Medical Center. However, the early stage requirements of Previvo presented a different set of challenges altogether.

Previvo’s large range of needs, combined with its founder’s innate trust, led the company to include ID’s Jeffrey Prag as a member of the executive management team, serving as Vice President, Marketing and Commercialization. By making this decision, Previvo gained access to a full set of marketing and commercialization capabilities, without incurring the costs of a full-time staff.

“Jeff and the team at ID have been with me from the very beginning with an acute focus and unwavering commitment to see the company succeed. They led us from concept and patent drawings, to naming the company, to developing our commercialization infrastructure. They have been an invaluable member of the team helping us achieve key milestones, facilitating fundraising and company buildout. I feel fortunate to have a true partner who put company needs first, willing to challenge the status quo all while looking ahead.”

- John E. Buster, M.D., Founder, Inventor & Board Member

Key initiatives include:

Measurable Impact

Moved Concept to Patent Raised over $25M in Funding First

Initial Design has worked with Previvo from its early inception and has been a critical component in the company’s progress through numerous milestones from patent applications to first in human trials. Additionally, ID and Previvo have worked to established a strong brand foundation for the eventual entry in the growing minimally invasive genetic testing market.